首页> 外文OA文献 >Zoledronic Acid and Survival in Patients with Metastatic Bone Disease From Lung Cancer and Elevated Markers of Osteoclast Activity: A Novel Molecular Mechanism

【2h】

Zoledronic Acid and Survival in Patients with Metastatic Bone Disease From Lung Cancer and Elevated Markers of Osteoclast Activity: A Novel Molecular Mechanism

机译：唑来膦酸与肺癌转移性骨疾病患者的生存及破骨细胞活性升高的标记物：一种新的分子机制

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Namazi Hamid;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity: a novel molecular mechanism. [J] . Namazi H Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2008,第8期

机译：唑来膦酸与肺癌转移性骨病患者的生存和破骨细胞活性标记升高：一种新的分子机制。
2. Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity. [J] . Hirsh V, Major PP, Lipton A, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2008,第3期

机译：唑来膦酸与肺癌转移性骨病患者的生存和破骨细胞活性标记升高有关。
3. Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity. [J] . Lipton A, Cook RJ, Major P, The oncologist . 2007,第9期

机译：唑来膦酸与乳腺癌患者的骨转移和破骨细胞活性标记升高的生存率。
4. Radium-223 Dichloride Monotherapy and Combination Therapy with Zoledronic Acid or Doxorubicin Improve Survival in a Mouse Model of Breast Cancer Bone Metastasis [C] . Jukka Rissanen, Mari Suominen, Rami K?k?nen, Molecular Medicine TRI-CON. . 2014

机译：镭-223二氯化物单疗法和组合治疗唑醇或多柔比星改善了乳腺癌骨转移的小鼠模型中的存活
5. Elucidating the Molecular Mechanisms of Zoledronic Acid in Breast Cancer. [D] . Schech, Amanda J. 2012

机译：阐明唑来膦酸在乳腺癌中的分子机制。
6. Usefulness of bone turnover markers as predictors of mortality risk disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study [O] . C de la Piedra, A Alcaraz, J Bellmunt, 2013

机译：唑来膦酸治疗后骨转移的前列腺癌患者的骨转换指标可作为预测死亡风险疾病进展和骨骼相关事件的指标：TUGAMO研究
7. Zoledronic Acid and Survival in Patients with Metastatic Bone Disease from Lung Cancer and Elevated Markers of Osteoclast Activity [O] . Hirsh Vera, Major Pierre P., Lipton Allan, 2008

机译：唑来膦酸与肺癌转移性骨病患者的生存率和破骨细胞活性标记升高

Zoledronic Acid and Survival in Patients with Metastatic Bone Disease From Lung Cancer and Elevated Markers of Osteoclast Activity: A Novel Molecular Mechanism

著录项

引文网络

相似文献

相关主题

期刊订阅